{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-021880","form_type":"8-K","ticker":"OCEA","cik":"0001869974","company_name":"Ocean Biomedical, Inc.","filed_at":"2024-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.030746+00:00","generated_at":"2026-06-01T07:28:56.876953+00:00","sec_items":["3.01","7.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ocean Biomedical receives Nasdaq non-compliance notice for late Q1 2024 10-Q filing","bullets":["Nasdaq notice received May 22, 2024 due to failure to file Form 10-Q for period ended March 31, 2024.","Company must submit a plan to regain compliance by June 14, 2024, and file delinquent 10-Q by October 14, 2024.","No immediate effect on listing or trading of OCEA common stock or OCEAW warrants, but further delays could impact.","Ocean Biomedical cites previously disclosed delays from its 2023 10-K as the cause.","Company intends to file the delinquent Form 10-Q as soon as practicable."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-021880","json":"https://secwatch.observer/filing/0001493152-24-021880.json","markdown":"https://secwatch.observer/filing/0001493152-24-021880.md","text":"https://secwatch.observer/filing/0001493152-24-021880.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1869974/000149315224021880/0001493152-24-021880-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1869974/000149315224021880/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:28:56.876953+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}